Northwest Bioth Cmn (NWBO)

$0.26 +0.00 (1.65%)
Market Cap 405.51M
Revenue (ttm) 1.38M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,071.01%
Debt to Equity Ratio 0.00
Volume 1,867,600
Avg Vol 3,407,590
Day's Range N/A - N/A
Shares Out 1.59B
Stochastic %K 28%
Beta -0.86
Analysts Strong Buy
Price Target $2.00

Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inop...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 497 9024
Address:
4800 Montgomery Lane, Suite 800, Bethesda, United States
Twister8
Twister8 May. 16 at 12:04 AM
$NWBO Redfin and sandwiches… the future is bright cultists!
0 · Reply
None_
None_ May. 15 at 11:47 PM
$NWBO https://x.com/adamfeuerstein/status/2055408560729735341
1 · Reply
Cocacola1971
Cocacola1971 May. 15 at 11:43 PM
$NWBO everyone on this board please block C@@@@M@@@@@. Obvious short who will end up with glioblastoma begging for treatment but doesn’t deserve it. As someone who has had cancer I would like to tell that idiot F$&@ O$$ Y +# P&$?: O£ 💩!!! There is a special place in hell for you my friend!! In fact, Just had another surgery with a Cathader in for 2 days last week realted to my 2024 diagnosis for prostate cancer. 🤬🤬 People like CM are just plain evil, soulless manipulated entities of the devil himself. That dude needs to find Jesus quickly!!!!
1 · Reply
MOneyMoney111
MOneyMoney111 May. 15 at 11:37 PM
$NWBO
0 · Reply
LongBullish
LongBullish May. 15 at 11:17 PM
$BFRI The positive bullish catalyst for Biofrontera Inc. stems from a combination of strong margin expansion in its recent Q1 2026 earnings report and an accelerating FDA regulatory pipeline for its flagship drug-light combination, Ameluz® PDT. While the company technically missed absolute revenue and EPS estimates due to temporary legal and selling costs, multiple operational milestones highlight substantial long-term growth potential. $NWBO should be next with positive bullish Catalysts for DCVAX-L. $NVDA doing well and $PLTR should recover soon.
0 · Reply
broken_zamboni
broken_zamboni May. 15 at 11:10 PM
$NWBO so having failed at being a biopharm company, NWBO has switched to real estate
0 · Reply
yensid
yensid May. 15 at 10:59 PM
$NWBO Some of the information in today’s 10-Q. Sounds promising!
0 · Reply
Bajamike
Bajamike May. 15 at 10:47 PM
$NWBO MAA Application. Much of the Company’s time and resources continued to be devoted to active engagement in the MAA review process during the first quarter. The Company continued to work with large teams of consultants on this process. As is typical, and as the Company has previously stated, the Company does not plan to make any interim announcements while its MAA is going through the regulatory process. The Company plans to announce the results when the regulatory review and decision-making is finished.
0 · Reply
Twister8
Twister8 May. 15 at 10:08 PM
$NWBO just can’t make this shit up…
0 · Reply
sDinvestments1
sDinvestments1 May. 15 at 9:58 PM
$NWBO fda submission in 2q this year 🙌🙌
2 · Reply
Latest News on NWBO
No data available.
Twister8
Twister8 May. 16 at 12:04 AM
$NWBO Redfin and sandwiches… the future is bright cultists!
0 · Reply
None_
None_ May. 15 at 11:47 PM
$NWBO https://x.com/adamfeuerstein/status/2055408560729735341
1 · Reply
Cocacola1971
Cocacola1971 May. 15 at 11:43 PM
$NWBO everyone on this board please block C@@@@M@@@@@. Obvious short who will end up with glioblastoma begging for treatment but doesn’t deserve it. As someone who has had cancer I would like to tell that idiot F$&@ O$$ Y +# P&$?: O£ 💩!!! There is a special place in hell for you my friend!! In fact, Just had another surgery with a Cathader in for 2 days last week realted to my 2024 diagnosis for prostate cancer. 🤬🤬 People like CM are just plain evil, soulless manipulated entities of the devil himself. That dude needs to find Jesus quickly!!!!
1 · Reply
MOneyMoney111
MOneyMoney111 May. 15 at 11:37 PM
$NWBO
0 · Reply
LongBullish
LongBullish May. 15 at 11:17 PM
$BFRI The positive bullish catalyst for Biofrontera Inc. stems from a combination of strong margin expansion in its recent Q1 2026 earnings report and an accelerating FDA regulatory pipeline for its flagship drug-light combination, Ameluz® PDT. While the company technically missed absolute revenue and EPS estimates due to temporary legal and selling costs, multiple operational milestones highlight substantial long-term growth potential. $NWBO should be next with positive bullish Catalysts for DCVAX-L. $NVDA doing well and $PLTR should recover soon.
0 · Reply
broken_zamboni
broken_zamboni May. 15 at 11:10 PM
$NWBO so having failed at being a biopharm company, NWBO has switched to real estate
0 · Reply
yensid
yensid May. 15 at 10:59 PM
$NWBO Some of the information in today’s 10-Q. Sounds promising!
0 · Reply
Bajamike
Bajamike May. 15 at 10:47 PM
$NWBO MAA Application. Much of the Company’s time and resources continued to be devoted to active engagement in the MAA review process during the first quarter. The Company continued to work with large teams of consultants on this process. As is typical, and as the Company has previously stated, the Company does not plan to make any interim announcements while its MAA is going through the regulatory process. The Company plans to announce the results when the regulatory review and decision-making is finished.
0 · Reply
Twister8
Twister8 May. 15 at 10:08 PM
$NWBO just can’t make this shit up…
0 · Reply
sDinvestments1
sDinvestments1 May. 15 at 9:58 PM
$NWBO fda submission in 2q this year 🙌🙌
2 · Reply
sDinvestments1
sDinvestments1 May. 15 at 9:53 PM
$NWBO Alot of nice nuggets and statements in this filing. Multiple posts incoming . Multiple Defensants wish to settle. Settlement money is in ana escrow account now .
4 · Reply
WTFKNOWS
WTFKNOWS May. 15 at 9:17 PM
$NWBO every single think has been fucked up by her. The cult refuses to acknowledge this. Stupid lemmings read the q and open your eyes. Why every one os not flooding her email demanding her resignation is beyond me.
0 · Reply
Smizzrizz
Smizzrizz May. 15 at 9:13 PM
$NWBO http://archive.fast-edgar.com/20260515/AIB2922C8Z22TTZ222TP2ZZZATD9H2W2N282
1 · Reply
WTFKNOWS
WTFKNOWS May. 15 at 9:11 PM
$NWBO Just as i said advent was trojan horse. Lol
0 · Reply
mymadeupname
mymadeupname May. 15 at 8:05 PM
$NWBO Have a great weekend my fellow bulls, LONG AND STRONG!!!!!!
1 · Reply
wjmax
wjmax May. 15 at 7:23 PM
$NWBO Dr. Annalisa Jenkins has been a non executive director of Mereo BioPharma since September 2022 and Baker Brothers have Mereo BioPharma in their portfolio too!!! https://find-and-update.company-information.service.gov.uk/company/09481161/filing-history/MzM1ODc5NTM0N2FkaXF6a2N4/document?format=pdf&download=0 BAKER BROS. ADVISORS LP Acquires Significant Stake in Mereo BioPharma Group PLC https://finance.yahoo.com/news/baker-bros-advisors-lp-acquires-030414796.html
0 · Reply
mymadeupname
mymadeupname May. 15 at 7:17 PM
$NWBO Hey my good people. Please do not respond to or share basher post like the one below. Somehow these cucks survived their mothers hangers to live on and be a pestilence to the board. They likely get judas coin for every interaction to their post, lets not give them a single cent. We know what we hold and we look forward to celebrating approval and lives being saved!!! And by the way, that's a screenshot not an actual share.
7 · Reply
pepinjax
pepinjax May. 15 at 7:15 PM
$NWBO blocked the clown! 🤡🤣
2 · Reply
wjmax
wjmax May. 15 at 7:13 PM
$NWBO Dr. Annalisa Jenkins was a member of the supervisory board of Prosensa between Aug 2014 and Oct 2015. Prosensa was acquired by Biomarin in November 2014 and Baker Brothers were the stockholder of Biomarin. Coincidence?! https://firstwordpharma.com/story/1811775 https://www.fiercebiotech.com/biotech/biomarin-buys-prosensa-for-up-to-840m-shoots-for-quick-ok-of-duchenne-drug https://www.sec.gov/Archives/edgar/data/1263508/000114420414068894/xslForm13F_X01/primary_doc.xml
0 · Reply
Jjscans
Jjscans May. 15 at 6:55 PM
$NWBO
0 · Reply
IMMUGILD
IMMUGILD May. 15 at 6:37 PM
$NWBO holding nicely , let’s get some news soon ! This is cool lotto ticket holding this . It’s fun to read all the bears comments . I truly hope they are all short on this . I don’t even belive they have positions or they would post profit when this has gone down for so long as they put it. Imagine posting every day on ticker you don’t even own or short ., yet that’s what they do . Oh yeah this is what my kids would call “rage bait” post kind of … I’m sure I’ll get few loser bears all worked up as they read this 🤣😂😆👍
1 · Reply
KSParker777
KSParker777 May. 15 at 6:18 PM
$NWBO Added for last time today and again
0 · Reply